首页/数据集/Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers

ChEBI2011-05-24 更新2026-07-21 收录

卵巢透明细胞癌

治疗靶点识别

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-29450 数据链接链接失效反馈

官方服务：

资源简介：

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers

应用场景：

创建时间：

2011-05-24

白血病分子机制

治疗靶点识别

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series

NIAID Data Ecosystem40

Additional file 1 of Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma

卵巢透明细胞癌

肿瘤分子特征

Additional file 1: Supplementary Table 1. List of the differentially expressed genes and results of the enriched gene set analysis associated with Figure 5.

Figshare2024-08-14 更新10

Features of venous thromboembolism (VTE) in ovarian clear cell carcinoma.

卵巢透明细胞癌

静脉血栓栓塞临床特征

Abbreviations: VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism.Features of venous thromboembolism (VTE) in ovarian clear cell carcinoma.

Figshare2015-12-03 更新10

Additional file 2 of Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer

癌症预后模型

治疗靶点识别

Additional file 2. Table S1: KEGG enrichment analysis of DEIGs.

Figshare2023-05-09 更新20

DataSheet4_Loss of the fructose transporter SLC2A5 inhibits cancer cell migration.PDF

癌症转移机制

治疗靶点识别

Metastasis is the primary cause of cancer patient death and the elevation of SLC2A5 gene expression is often observed in metastatic cancer cells. Here we evaluated the importance of SLC2A5 in cancer c

NIAID Data Ecosystem10

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers

资源简介：

相关数据集